Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial
Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedGurgaon location entries were updated to the diacritic form 'Gūrgaon' (two entries). The page revision tag changed from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded a glossary and a new 'Last Update Submitted that Met QC Criteria' field; updated the FEAR Act label to 'No FEAR Act Data' and revised the version from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, a minor metadata change that does not affect study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section updated with new trial sites across multiple countries, including the United States (many states) and international regions. Some previously listed locations were removed.SummaryDifference2%

- Check70 days agoChange DetectedAdded Gūrgaon, India, 122001 and 122002 as location entries and removed Gurgaon, India, 122001 and 122002. The city name is now displayed with the diacritic.SummaryDifference0.0%

Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.